The importance of GLP-1 and PYY in resistant starch's effect on body fat in mice

Resistant starch (RS) is a dietary fermentable fiber that decreases body fat accumulation, and stimulates the secretion of glucagon‐like peptide‐1 (GLP‐1) and peptide YY (PYY) in rodents. GLP‐1 and PYY are gut‐secreted hormones with antiobesity effect. Thus, blocking the signals of increased GLP‐1 a...

Full description

Saved in:

Bibliographic Details
Published in	Molecular nutrition & food research Vol. 59; no. 5; pp. 1000 - 1003
Main Authors	Zhou, June, Martin, Roy J., Raggio, Anne M., Shen, Li, McCutcheon, Kathleen, Keenan, Michael J.
Format	Journal Article
Language	English
Published	Germany Blackwell Publishing Ltd 01.05.2015
Subjects	Adipose Tissue - metabolism Animals Antagonist antagonists body fat body weight Dietary Fiber Dietary Fiber - pharmacology fermentation food intake gene expression genotype GLP-1 receptor glucagon-like peptide 1 Glucagon-Like Peptide 1 - blood Glucagon-Like Peptide 1 - physiology intraperitoneal injection messenger RNA Mice Obesity peptide YY Peptide YY - blood Peptide YY - physiology PYY receptor resistant starch secretion Starch - pharmacology Obesity Dietary Fiber Antagonist GLP-1 receptor PYY receptor
Online Access	Get full text

Cover

Loading…

Abstract	Resistant starch (RS) is a dietary fermentable fiber that decreases body fat accumulation, and stimulates the secretion of glucagon‐like peptide‐1 (GLP‐1) and peptide YY (PYY) in rodents. GLP‐1 and PYY are gut‐secreted hormones with antiobesity effect. Thus, blocking the signals of increased GLP‐1 and PYY may also block the effect of dietary RS on body fat. In a 10‐week study, C57BL/6J and GLP‐1 receptor null (GLP‐1R KO) mice were fed control or 30% RS diet, and received daily intraperitoneal injection of either saline or PYY receptor antagonist (BIIE0246, 20 μg/kg body weight). Dietary RS significantly decreased body fat accumulation only in wild‐type mice that has saline injection, but not in GLP‐1R KO mice. PYY receptor antagonist diminished RS action on body fat in wild‐type mice, but did not interfere with GLP‐1R KO mice response to RS. Regardless of genotype and injection received, all RS‐fed mice had increased cumulative food intake, cecal fermentation, and mRNA expression of proglucagon and PYY. Thus, our results suggest that increased GLP‐1 and PYY is important in RS effects on body fat accumulation.
AbstractList	Resistant starch (RS) is a dietary fermentable fiber that decreases body fat accumulation, and stimulates the secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) in rodents. GLP-1 and PYY are gut-secreted hormones with antiobesity effect. Thus, blocking the signals of increased GLP-1 and PYY may also block the effect of dietary RS on body fat. In a 10-week study, C57BL/6J and GLP-1 receptor null (GLP-1R KO) mice were fed control or 30% RS diet, and received daily intraperitoneal injection of either saline or PYY receptor antagonist (BIIE0246, 20 μg/kg body weight). Dietary RS significantly decreased body fat accumulation only in wild-type mice that has saline injection, but not in GLP-1R KO mice. PYY receptor antagonist diminished RS action on body fat in wild-type mice, but did not interfere with GLP-1R KO mice response to RS. Regardless of genotype and injection received, all RS-fed mice had increased cumulative food intake, cecal fermentation, and mRNA expression of proglucagon and PYY. Thus, our results suggest that increased GLP-1 and PYY is important in RS effects on body fat accumulation.Resistant starch (RS) is a dietary fermentable fiber that decreases body fat accumulation, and stimulates the secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) in rodents. GLP-1 and PYY are gut-secreted hormones with antiobesity effect. Thus, blocking the signals of increased GLP-1 and PYY may also block the effect of dietary RS on body fat. In a 10-week study, C57BL/6J and GLP-1 receptor null (GLP-1R KO) mice were fed control or 30% RS diet, and received daily intraperitoneal injection of either saline or PYY receptor antagonist (BIIE0246, 20 μg/kg body weight). Dietary RS significantly decreased body fat accumulation only in wild-type mice that has saline injection, but not in GLP-1R KO mice. PYY receptor antagonist diminished RS action on body fat in wild-type mice, but did not interfere with GLP-1R KO mice response to RS. Regardless of genotype and injection received, all RS-fed mice had increased cumulative food intake, cecal fermentation, and mRNA expression of proglucagon and PYY. Thus, our results suggest that increased GLP-1 and PYY is important in RS effects on body fat accumulation. Resistant starch (RS) is a dietary fermentable fiber that decreases body fat accumulation, and stimulates the secretion of glucagon‐like peptide‐1 (GLP‐1) and peptide YY (PYY) in rodents. GLP‐1 and PYY are gut‐secreted hormones with antiobesity effect. Thus, blocking the signals of increased GLP‐1 and PYY may also block the effect of dietary RS on body fat. In a 10‐week study, C57BL/6J and GLP‐1 receptor null (GLP‐1R KO) mice were fed control or 30% RS diet, and received daily intraperitoneal injection of either saline or PYY receptor antagonist (BIIE0246, 20 μg/kg body weight). Dietary RS significantly decreased body fat accumulation only in wild‐type mice that has saline injection, but not in GLP‐1R KO mice. PYY receptor antagonist diminished RS action on body fat in wild‐type mice, but did not interfere with GLP‐1R KO mice response to RS. Regardless of genotype and injection received, all RS‐fed mice had increased cumulative food intake, cecal fermentation, and mRNA expression of proglucagon and PYY. Thus, our results suggest that increased GLP‐1 and PYY is important in RS effects on body fat accumulation. Resistant starch (RS) is a dietary fermentable fiber that decreases body fat accumulation, and stimulates the secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) in rodents. GLP-1 and PYY are gut secreted hormones with anti-obesity effect. Thus, blocking the signals of increased GLP-1 and PYY may also block the effect of dietary RS on body fat. In a ten-week study, C57BL/6J and GLP-1 receptor null (GLP-1R KO) mice were fed control or 30% RS diet, and received daily intraperitoneal injection of either saline or PYY receptor antagonist (BIIE 0246, 20ug/kg body weight). Dietary RS significantly decreased body fat accumulation only in wild type mice that has saline injection, but not in GLP-1R KO mice. PYY receptor antagonist diminished RS action on body fat in wild type mice, but did not interfere with GLP-1R KO mice response to RS. Regardless of genotype and injection received, all RS fed mice had increased cumulative food intake, cecal fermentation, and mRNA expression of proglucagon and PYY. Thus, our results suggest that increased GLP-1 and PYY is important in RS effects on body fat accumulation.
Author	McCutcheon, Kathleen Shen, Li Raggio, Anne M. Martin, Roy J. Keenan, Michael J. Zhou, June
AuthorAffiliation	1 Pennington Biomedical Research Center, Baton Rouge, LA 70808 3 Louisiana State University AgCenter, Baton Rouge, LA 70803 2 Veterans Affairs Medical Center Washington DC 20422
AuthorAffiliation_xml	– name: 2 Veterans Affairs Medical Center Washington DC 20422 – name: 3 Louisiana State University AgCenter, Baton Rouge, LA 70803 – name: 1 Pennington Biomedical Research Center, Baton Rouge, LA 70808
Author_xml	– sequence: 1 givenname: June surname: Zhou fullname: Zhou, June email: june.zhou@va.gov organization: Pennington Biomedical Research Center, Baton Rouge, LA, USA – sequence: 2 givenname: Roy J. surname: Martin fullname: Martin, Roy J. organization: Pennington Biomedical Research Center, Baton Rouge, LA, USA – sequence: 3 givenname: Anne M. surname: Raggio fullname: Raggio, Anne M. organization: Pennington Biomedical Research Center, Baton Rouge, LA, USA – sequence: 4 givenname: Li surname: Shen fullname: Shen, Li organization: Pennington Biomedical Research Center, Baton Rouge, LA, USA – sequence: 5 givenname: Kathleen surname: McCutcheon fullname: McCutcheon, Kathleen organization: Louisiana State University AgCenter, LA, Baton Rouge, USA – sequence: 6 givenname: Michael J. surname: Keenan fullname: Keenan, Michael J. organization: Pennington Biomedical Research Center, Baton Rouge, LA, USA
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/25631638$$D View this record in MEDLINE/PubMed
BookMark	eNqFkUtv1DAUhSNURB-wZYm8g00Gv5NskFBFp0jTMipFqCvLca4ZQ2IPdoZ2_j0eTYmAzWxsy_c7x9f3nBZHPngoipcEzwjG9O3gbZxRTDjGDeZPihMiCSs5YexoOlNxXJym9B1jRihnz4pjKiQjktUnxfJ2BcgN6xBH7Q2gYNF8sSwJ0r5Dy7s75DyKkFzK5RHlNZrV64TAWjAjCh61odsiq8cdODgDz4unVvcJXjzuZ8WXiw-355fl4tP84_n7RWlEJWXZGNG2pmMcN7WGzgI1FCxUhNiKisZyBpK3wmLS4KaiHQCnNt8bY3AnMbCz4t3ed71pB-gM-DHqXq2jG3TcqqCd-rfi3Up9C7-UEILRBmeDN48GMfzcQBrV4JKBvtcewiYpUudxEUEYPYzKGpOaYcky-urvtqZ-_kw8A7M9YGJIKYKdEILVLlK1i1RNkWYB_09g3KhHF3bfcv1B2b3rYXvgEXV1fXFDGZdZVu5lOXF4mGQ6_lCyYpVQX6_nStBLSm6uuPrMfgMdmsNd
CitedBy_id	crossref_primary_10_3390_nu11010156 crossref_primary_10_1016_j_fbio_2023_102644 crossref_primary_10_3390_foods11192980 crossref_primary_10_1016_j_ijbiomac_2019_08_032 crossref_primary_10_1016_j_foodhyd_2017_09_019 crossref_primary_10_1186_s12937_015_0104_2 crossref_primary_10_29219_fnr_v64_3525 crossref_primary_10_1186_s13099_016_0149_6 crossref_primary_10_3389_fcimb_2020_00188 crossref_primary_10_1186_s40168_017_0230_5 crossref_primary_10_1097_MCO_0000000000000223 crossref_primary_10_1038_s41538_025_00403_0 crossref_primary_10_3389_fnut_2022_861854 crossref_primary_10_3389_fendo_2019_00082 crossref_primary_10_1016_j_foodhyd_2021_106949 crossref_primary_10_1093_nutrit_nuae040 crossref_primary_10_1152_ajpendo_00391_2018 crossref_primary_10_1096_fj_202403239R crossref_primary_10_3390_foods11193028 crossref_primary_10_1002_jsfa_12756 crossref_primary_10_1002_star_201600205 crossref_primary_10_1186_s12937_017_0235_8 crossref_primary_10_1016_j_jff_2018_12_041 crossref_primary_10_3390_nu15010151 crossref_primary_10_1016_j_gene_2017_08_028 crossref_primary_10_3390_nu14183802 crossref_primary_10_3390_md18020097 crossref_primary_10_1016_j_ijbiomac_2017_11_105 crossref_primary_10_1016_j_mehy_2018_06_032 crossref_primary_10_1038_ejcn_2016_249 crossref_primary_10_3390_nu11092066 crossref_primary_10_3390_foods12122310 crossref_primary_10_3748_wjg_v27_i18_2219 crossref_primary_10_1016_j_foodres_2023_113215 crossref_primary_10_1080_13543776_2023_2274905 crossref_primary_10_1097_MPG_0000000000001857 crossref_primary_10_1016_j_psj_2024_103570 crossref_primary_10_1039_C7FO01820G crossref_primary_10_3389_fmicb_2022_1073350 crossref_primary_10_3390_microorganisms11071725
Cites_doi	10.1021/jf901548e 10.1097/00001574-200003000-00014 10.1007/978-1-4615-5967-2_21 10.1038/oby.2008.483 10.1080/10408398.2011.629352 10.1038/oby.2006.176 10.1002/mnfr.201000605 10.1159/000335319 10.1097/MOG.0b013e32835b9aa3 10.3920/BM2010.0041 10.1152/ajpendo.90637.2008 10.1007/978-3-642-38007-5_22 10.1002/oby.20501 10.1038/ijo.2012.227 10.1002/mnfr.200500025 10.1155/2010/651063 10.1002/mnfr.201300135 10.1002/oby.20109 10.1210/en.2005-0473 10.1038/oby.2006.77 10.1210/en.2005-0237 10.1016/j.brainres.2005.02.065 10.1124/mol.109.058677
ContentType	Journal Article
Copyright	2015 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Copyright_xml	– notice: 2015 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim – notice: 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
DBID	BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 5PM
DOI	10.1002/mnfr.201400904
DatabaseName	Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic
DatabaseTitleList	MEDLINE - Academic AGRICOLA CrossRef MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Diet & Clinical Nutrition
EISSN	1613-4133
EndPage	1003
ExternalDocumentID	PMC5553290 25631638 10_1002_mnfr_201400904 MNFR2346 ark_67375_WNG_52H21RM4_S
Genre	article Journal Article Research Support, N.I.H., Extramural
GrantInformation_xml	– fundername: NIH funderid: R21 DK073403 – fundername: NIDDK NIH HHS grantid: P30 DK072476 – fundername: NIDDK NIH HHS grantid: R21 DK073403
GroupedDBID	--- .3N .GA .Y3 05W 0R~ 10A 123 1L6 1OC 31~ 33P 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHBH AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCUV ABIJN ABJNI ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACIWK ACPOU ACPRK ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AUFTA AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BSCLL BY8 C45 CS3 D-E D-F DCZOG DPXWK DR2 DRFUL DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.T H.X HF~ HGLYW HHZ HVGLF HZ~ IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2W P2X P4D Q.N Q11 QB0 QRW R.K ROL RWI RX1 RYL SUPJJ SV3 TEORI UB1 V8K W8V W99 WBKPD WIH WIK WJL WNSPC WOHZO WXSBR WYISQ XG1 XV2 Y6R ~IA ~KM ~WT AAHQN AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AFWVQ ALVPJ DROCM AAFWJ AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 1OB 5PM
ID	FETCH-LOGICAL-c5766-9c5bbcd34098aedfe2c2efe711f7259f43e64b5f0190972dee42f59fccc0d60e3
IEDL.DBID	DR2
ISSN	1613-4125 1613-4133
IngestDate	Thu Aug 21 13:52:42 EDT 2025 Fri Jul 11 18:32:32 EDT 2025 Fri Jul 11 05:54:19 EDT 2025 Mon Jul 21 06:04:59 EDT 2025 Tue Jul 01 01:51:39 EDT 2025 Thu Apr 24 23:07:12 EDT 2025 Wed Jan 22 16:29:26 EST 2025 Wed Oct 30 09:52:11 EDT 2024
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	5
Keywords	Obesity Dietary Fiber Antagonist GLP-1 receptor PYY receptor
Language	English
License	http://onlinelibrary.wiley.com/termsAndConditions#vor 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c5766-9c5bbcd34098aedfe2c2efe711f7259f43e64b5f0190972dee42f59fccc0d60e3
Notes	ArticleID:MNFR2346 ark:/67375/WNG-52H21RM4-S NIH - No. R21 DK073403 istex:2821C6AD15026E95E4EDDBE8B14ED798BDD1B0D4 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Current address: Laboratory of Geriatric Endocrinology and Metabolism, Veterans Affairs Medical Center, 50 Irving Street, NW, Washington, DC 20422, USA, Phone: 202-745-8000 ext. 5294, Fax: 202-518-4611, june.zhou@va.gov
OpenAccessLink	http://doi.org/10.1002/mnfr.201400904
PMID	25631638
PQID	1680183063
PQPubID	23479
PageCount	4
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_5553290 proquest_miscellaneous_1803115132 proquest_miscellaneous_1680183063 pubmed_primary_25631638 crossref_primary_10_1002_mnfr_201400904 crossref_citationtrail_10_1002_mnfr_201400904 wiley_primary_10_1002_mnfr_201400904_MNFR2346 istex_primary_ark_67375_WNG_52H21RM4_S
ProviderPackageCode	CITATION AAYXX
PublicationCentury	2000
PublicationDate	May 2015
PublicationDateYYYYMMDD	2015-05-01
PublicationDate_xml	– month: 05 year: 2015 text: May 2015
PublicationDecade	2010
PublicationPlace	Germany
PublicationPlace_xml	– name: Germany
PublicationTitle	Molecular nutrition & food research
PublicationTitleAlternate	Mol. Nutr. Food Res
PublicationYear	2015
Publisher	Blackwell Publishing Ltd
Publisher_xml	– name: Blackwell Publishing Ltd
References	Asp, N. G., Resistant starch-an update on its physiological effects. Adv. Exp. Med. Biol. 1997, 427, 201-210. Zhou, J., Hegsted, M., McCutcheon, K. L., Keenan, M. J. et al., Peptide YY and proglucagon mRNA expression patterns and regulation in the gut. Obesity 2006, 14, 683-689. Keenan, M. J., Martin, R. J., Raggio, A. M., McCutcheon, K. L. et al., High-amylose resistant starch increases hormones and improves structure and function of the gastrointestinal tract: a microarray study. J. Nutrigenet. Nutrigenomics 2012, 5, 26-44. Hullar, M. A., Burnett-Hartman, A. N., Lampe, J. W., Gut microbes, diet, and cancer. Cancer Treat. Res. 2014, 159, 377-399. Talsania, T., Anini, Y., Siu, S., Drucker, D. J. et al., Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice. Endocrinology 2005, 146, 3748-3756. Zhou, J., Martin, R. J., Tulley, R. T., Raggio, A. M. et al., Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am. J. Physiol. Endocrinol. Metab. 2008, 295, E1160-E1166. Vidrine, K., Ye, J., Martin, R. J., McCutcheon, K. L. et al., Resistant starch from high amylose maize (HAM-RS2) and Dietary butyrate reduce abdominal fat by a different apparent mechanism. Obesity 2013, 22, 344-348. Parker, J. A., McCullough, K. A., Field, B. C., Minnion, J. S. et al., Glucagon and GLP-1 inhibit food intake and increase c-fos expression in similar appetite regulating centres in the brainstem and amygdala. Int. J. Obes. 2013, 37, 1391-1398. Garcia, T. A., McCutcheon, K. L., Francis, A. R., Keenan, M. J. et al., The effects of resistant starch on gastrointestinal organs and fecal output in rats. FASEB J. 2003, 17, A335. Keenan, M. J., Janes, M., Robert, J., Martin, R. J. et al., Resistant starch from high amylose maize (HAM-RS2) reduces body fat and increases gut bacteria in ovariectomized (OVX) rats. Obesity (Silver Spring) 2013, 21, 981-984. Abbott, C. R., Small, C. J., Kennedy, A. R., Neary, N. M. et al., Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake. Brain Res. 2005, 1043, 139-144. Neary, N. M., Small, C. J., Druce, M. R., Park, A. J. et al., Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology 2005, 146, 5120-5127. Keenan, M. J., Zhou, J., McCutcheon, K. L., Raggio, A. M. et al., Effects of resistant starch, a non-digestible fermentable fiber, on reducing body fat. Obesity 2006, 14, 1523-1534. Zhou, J., Keenan, M. J., Fernandez-Kim, S. O., Pistell, P. J. et al., Dietary resistant starch improves selected brain and behavioral functions in adult and aged rodents. Mol. Nutr. Food Res. 2013, 57, 2071-2074. Shen, L., Keenan, M. J., Martin, R. J., Tulley, R. T. et al., Dietary resistant starch increases hypothalamic POMC expression in rats. Obesity 2009, 17, 40-45. Brothers, S. P., Saldanha, S. A., Spicer, T. P., Cameron, M. et al., Selective and brain penetrant neuropeptide y y2 receptor antagonists discovered by whole-cell high-throughput screening. Mol. Pharmacol. 2010, 77, 46-57. Brennan, C. S., Dietary fibre, glycaemic response, and diabetes. Mol. Nutr. Food Res. 2005, 49, 560-570. Al-Tamimi, E. K., Seib, P. A., Snyder, B. S., Haub, M. D., Consumption of cross-linked resistant starch (RS4(XL)) on glucose and insulin responses in humans. J. Nutr. Metab. 2010, 2010, doi: 10.1155/2010/651063. Zhou, J., Martin, R. J., Tulley, R. T., Raggio, A. M. et al., Failure to ferment dietary resistant starch in specific mouse models of obesity results in no body fat loss. J. Agric. Food Chem. 2009, 57, 8844-8851. Jenkins, D. J., Kendall, C. W., Resistant starches. Curr. Opin. Gastroenterol. 2000, 16, 178-183. Higgins, J. A., Brown, I. L., Resistant starch: a promising dietary agent for the prevention/treatment of inflammatory bowel disease and bowel cancer. Curr. Opin. Gastroenterol. 2013, 29, 190-194. Higgins, J. A., Resistant starch and energy balance: impact on weight loss and maintenance. Crit. Rev. Food Sci. Nutr. 2014, 54, 1158-1166. Bird, A. R., Conlon, M. A., Christophersen, C. T., Topping, D. L., Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics. Benef. Microbes 2011, 1, 423-431. Shen, L., Keenan, M. J., Raggio, A., Williams, C. et al., Dietary-resistant starch improves maternal glycemic control in Goto-Kakizaki rat. Mol. Nutr. Food Res. 2011, 55, 1499-1508. 2013; 29 2010; 77 2009; 57 2013; 37 1997; 427 2000; 16 2010; 2010 2011; 1 2013; 22 2013; 21 2013; 57 2005; 146 2006; 14 2005; 1043 2011; 55 2003; 17 2005; 49 2012; 5 2008; 295 2014; 159 2014; 54 2009; 17 e_1_2_5_15_1 e_1_2_5_14_1 Garcia T. A. (e_1_2_5_9_1) 2003; 17 e_1_2_5_17_1 e_1_2_5_25_1 e_1_2_5_16_1 e_1_2_5_8_1 e_1_2_5_11_1 e_1_2_5_23_1 e_1_2_5_7_1 e_1_2_5_10_1 e_1_2_5_24_1 e_1_2_5_6_1 e_1_2_5_13_1 e_1_2_5_21_1 e_1_2_5_5_1 e_1_2_5_12_1 e_1_2_5_22_1 e_1_2_5_4_1 e_1_2_5_3_1 e_1_2_5_2_1 e_1_2_5_19_1 e_1_2_5_18_1 e_1_2_5_20_1 23818307 - Mol Nutr Food Res. 2013 Nov;57(11):2071-4 23630079 - Obesity (Silver Spring). 2014 Feb;22(2):344-8 24499148 - Crit Rev Food Sci Nutr. 2014;54(9):1158-66 18948970 - Obesity (Silver Spring). 2009 Jan;17(1):40-5 18796545 - Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1160-6 9361845 - Adv Exp Med Biol. 1997;427:201-10 23784900 - Obesity (Silver Spring). 2013 May;21(5):981-4 15862527 - Brain Res. 2005 May 10;1043(1-2):139-44 22516953 - J Nutrigenet Nutrigenomics. 2012;5(1):26-44 23385525 - Curr Opin Gastroenterol. 2013 Mar;29(2):190-4 19739641 - J Agric Food Chem. 2009 Oct 14;57(19):8844-51 16741270 - Obesity (Silver Spring). 2006 Apr;14(4):683-9 24114492 - Cancer Treat Res. 2014;159:377-99 21831780 - Benef Microbes. 2010 Nov;1(4):423-31 19837904 - Mol Pharmacol. 2010 Jan;77(1):46-57 15926145 - Mol Nutr Food Res. 2005 Jun;49(6):560-70 23337772 - Int J Obes (Lond). 2013 Oct;37(10):1391-8 17030963 - Obesity (Silver Spring). 2006 Sep;14(9):1523-34 17024038 - Curr Opin Gastroenterol. 2000 Mar;16(2):178-83 21638778 - Mol Nutr Food Res. 2011 Oct;55(10 ):1499-508 16150917 - Endocrinology. 2005 Dec;146(12):5120-7 15932924 - Endocrinology. 2005 Sep;146(9):3748-56 20798767 - J Nutr Metab. 2010;2010:null
References_xml	– reference: Asp, N. G., Resistant starch-an update on its physiological effects. Adv. Exp. Med. Biol. 1997, 427, 201-210. – reference: Brennan, C. S., Dietary fibre, glycaemic response, and diabetes. Mol. Nutr. Food Res. 2005, 49, 560-570. – reference: Shen, L., Keenan, M. J., Raggio, A., Williams, C. et al., Dietary-resistant starch improves maternal glycemic control in Goto-Kakizaki rat. Mol. Nutr. Food Res. 2011, 55, 1499-1508. – reference: Abbott, C. R., Small, C. J., Kennedy, A. R., Neary, N. M. et al., Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake. Brain Res. 2005, 1043, 139-144. – reference: Al-Tamimi, E. K., Seib, P. A., Snyder, B. S., Haub, M. D., Consumption of cross-linked resistant starch (RS4(XL)) on glucose and insulin responses in humans. J. Nutr. Metab. 2010, 2010, doi: 10.1155/2010/651063. – reference: Vidrine, K., Ye, J., Martin, R. J., McCutcheon, K. L. et al., Resistant starch from high amylose maize (HAM-RS2) and Dietary butyrate reduce abdominal fat by a different apparent mechanism. Obesity 2013, 22, 344-348. – reference: Zhou, J., Martin, R. J., Tulley, R. T., Raggio, A. M. et al., Failure to ferment dietary resistant starch in specific mouse models of obesity results in no body fat loss. J. Agric. Food Chem. 2009, 57, 8844-8851. – reference: Bird, A. R., Conlon, M. A., Christophersen, C. T., Topping, D. L., Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics. Benef. Microbes 2011, 1, 423-431. – reference: Shen, L., Keenan, M. J., Martin, R. J., Tulley, R. T. et al., Dietary resistant starch increases hypothalamic POMC expression in rats. Obesity 2009, 17, 40-45. – reference: Zhou, J., Martin, R. J., Tulley, R. T., Raggio, A. M. et al., Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am. J. Physiol. Endocrinol. Metab. 2008, 295, E1160-E1166. – reference: Neary, N. M., Small, C. J., Druce, M. R., Park, A. J. et al., Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology 2005, 146, 5120-5127. – reference: Higgins, J. A., Resistant starch and energy balance: impact on weight loss and maintenance. Crit. Rev. Food Sci. Nutr. 2014, 54, 1158-1166. – reference: Parker, J. A., McCullough, K. A., Field, B. C., Minnion, J. S. et al., Glucagon and GLP-1 inhibit food intake and increase c-fos expression in similar appetite regulating centres in the brainstem and amygdala. Int. J. Obes. 2013, 37, 1391-1398. – reference: Zhou, J., Hegsted, M., McCutcheon, K. L., Keenan, M. J. et al., Peptide YY and proglucagon mRNA expression patterns and regulation in the gut. Obesity 2006, 14, 683-689. – reference: Hullar, M. A., Burnett-Hartman, A. N., Lampe, J. W., Gut microbes, diet, and cancer. Cancer Treat. Res. 2014, 159, 377-399. – reference: Zhou, J., Keenan, M. J., Fernandez-Kim, S. O., Pistell, P. J. et al., Dietary resistant starch improves selected brain and behavioral functions in adult and aged rodents. Mol. Nutr. Food Res. 2013, 57, 2071-2074. – reference: Keenan, M. J., Martin, R. J., Raggio, A. M., McCutcheon, K. L. et al., High-amylose resistant starch increases hormones and improves structure and function of the gastrointestinal tract: a microarray study. J. Nutrigenet. Nutrigenomics 2012, 5, 26-44. – reference: Keenan, M. J., Janes, M., Robert, J., Martin, R. J. et al., Resistant starch from high amylose maize (HAM-RS2) reduces body fat and increases gut bacteria in ovariectomized (OVX) rats. Obesity (Silver Spring) 2013, 21, 981-984. – reference: Talsania, T., Anini, Y., Siu, S., Drucker, D. J. et al., Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice. Endocrinology 2005, 146, 3748-3756. – reference: Keenan, M. J., Zhou, J., McCutcheon, K. L., Raggio, A. M. et al., Effects of resistant starch, a non-digestible fermentable fiber, on reducing body fat. Obesity 2006, 14, 1523-1534. – reference: Brothers, S. P., Saldanha, S. A., Spicer, T. P., Cameron, M. et al., Selective and brain penetrant neuropeptide y y2 receptor antagonists discovered by whole-cell high-throughput screening. Mol. Pharmacol. 2010, 77, 46-57. – reference: Higgins, J. A., Brown, I. L., Resistant starch: a promising dietary agent for the prevention/treatment of inflammatory bowel disease and bowel cancer. Curr. Opin. Gastroenterol. 2013, 29, 190-194. – reference: Jenkins, D. J., Kendall, C. W., Resistant starches. Curr. Opin. Gastroenterol. 2000, 16, 178-183. – reference: Garcia, T. A., McCutcheon, K. L., Francis, A. R., Keenan, M. J. et al., The effects of resistant starch on gastrointestinal organs and fecal output in rats. FASEB J. 2003, 17, A335. – volume: 54 start-page: 1158 year: 2014 end-page: 1166 article-title: Resistant starch and energy balance: impact on weight loss and maintenance publication-title: Crit. Rev. Food Sci. Nutr. – volume: 14 start-page: 1523 year: 2006 end-page: 1534 article-title: Effects of resistant starch, a non‐digestible fermentable fiber, on reducing body fat publication-title: Obesity – volume: 57 start-page: 8844 year: 2009 end-page: 8851 article-title: Failure to ferment dietary resistant starch in specific mouse models of obesity results in no body fat loss publication-title: J. Agric. Food Chem. – volume: 2010 year: 2010 article-title: Consumption of cross‐linked resistant starch (RS4(XL)) on glucose and insulin responses in humans publication-title: J. Nutr. Metab. – volume: 29 start-page: 190 year: 2013 end-page: 194 article-title: Resistant starch: a promising dietary agent for the prevention/treatment of inflammatory bowel disease and bowel cancer publication-title: Curr. Opin. Gastroenterol. – volume: 1043 start-page: 139 year: 2005 end-page: 144 article-title: Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3‐36) on food intake publication-title: Brain Res. – volume: 1 start-page: 423 year: 2011 end-page: 431 article-title: Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics publication-title: Benef. Microbes – volume: 16 start-page: 178 year: 2000 end-page: 183 article-title: Resistant starches publication-title: Curr. Opin. Gastroenterol. – volume: 17 start-page: A335 year: 2003 article-title: The effects of resistant starch on gastrointestinal organs and fecal output in rats publication-title: FASEB J. – volume: 159 start-page: 377 year: 2014 end-page: 399 article-title: Gut microbes, diet, and cancer publication-title: Cancer Treat. Res. – volume: 21 start-page: 981 year: 2013 end-page: 984 article-title: Resistant starch from high amylose maize (HAM‐RS2) reduces body fat and increases gut bacteria in ovariectomized (OVX) rats publication-title: Obesity (Silver Spring) – volume: 57 start-page: 2071 year: 2013 end-page: 2074 article-title: Dietary resistant starch improves selected brain and behavioral functions in adult and aged rodents publication-title: Mol. Nutr. Food Res. – volume: 146 start-page: 3748 year: 2005 end-page: 3756 article-title: Peripheral exendin‐4 and peptide YY(3‐36) synergistically reduce food intake through different mechanisms in mice publication-title: Endocrinology – volume: 49 start-page: 560 year: 2005 end-page: 570 article-title: Dietary fibre, glycaemic response, and diabetes publication-title: Mol. Nutr. Food Res. – volume: 14 start-page: 683 year: 2006 end-page: 689 article-title: Peptide YY and proglucagon mRNA expression patterns and regulation in the gut publication-title: Obesity – volume: 37 start-page: 1391 year: 2013 end-page: 1398 article-title: Glucagon and GLP‐1 inhibit food intake and increase c‐fos expression in similar appetite regulating centres in the brainstem and amygdala publication-title: Int. J. Obes. – volume: 17 start-page: 40 year: 2009 end-page: 45 article-title: Dietary resistant starch increases hypothalamic POMC expression in rats publication-title: Obesity – volume: 55 start-page: 1499 year: 2011 end-page: 1508 article-title: Dietary‐resistant starch improves maternal glycemic control in Goto‐Kakizaki rat publication-title: Mol. Nutr. Food Res. – volume: 295 start-page: E1160 year: 2008 end-page: E1166 article-title: Dietary resistant starch upregulates total GLP‐1 and PYY in a sustained day‐long manner through fermentation in rodents publication-title: Am. J. Physiol. Endocrinol. Metab. – volume: 5 start-page: 26 year: 2012 end-page: 44 article-title: High‐amylose resistant starch increases hormones and improves structure and function of the gastrointestinal tract: a microarray study publication-title: J. Nutrigenet. Nutrigenomics – volume: 77 start-page: 46 year: 2010 end-page: 57 article-title: Selective and brain penetrant neuropeptide y y2 receptor antagonists discovered by whole‐cell high‐throughput screening publication-title: Mol. Pharmacol. – volume: 22 start-page: 344 year: 2013 end-page: 348 article-title: Resistant starch from high amylose maize (HAM‐RS2) and Dietary butyrate reduce abdominal fat by a different apparent mechanism publication-title: Obesity – volume: 427 start-page: 201 year: 1997 end-page: 210 article-title: Resistant starch—an update on its physiological effects publication-title: Adv. Exp. Med. Biol. – volume: 146 start-page: 5120 year: 2005 end-page: 5127 article-title: Peptide YY3‐36 and glucagon‐like peptide‐17‐36 inhibit food intake additively publication-title: Endocrinology – ident: e_1_2_5_18_1 doi: 10.1021/jf901548e – volume: 17 start-page: A335 year: 2003 ident: e_1_2_5_9_1 article-title: The effects of resistant starch on gastrointestinal organs and fecal output in rats publication-title: FASEB J. – ident: e_1_2_5_8_1 doi: 10.1097/00001574-200003000-00014 – ident: e_1_2_5_5_1 doi: 10.1007/978-1-4615-5967-2_21 – ident: e_1_2_5_16_1 doi: 10.1038/oby.2008.483 – ident: e_1_2_5_3_1 doi: 10.1080/10408398.2011.629352 – ident: e_1_2_5_12_1 doi: 10.1038/oby.2006.176 – ident: e_1_2_5_17_1 doi: 10.1002/mnfr.201000605 – ident: e_1_2_5_15_1 doi: 10.1159/000335319 – ident: e_1_2_5_2_1 doi: 10.1097/MOG.0b013e32835b9aa3 – ident: e_1_2_5_6_1 doi: 10.3920/BM2010.0041 – ident: e_1_2_5_19_1 doi: 10.1152/ajpendo.90637.2008 – ident: e_1_2_5_4_1 doi: 10.1007/978-3-642-38007-5_22 – ident: e_1_2_5_13_1 doi: 10.1002/oby.20501 – ident: e_1_2_5_25_1 doi: 10.1038/ijo.2012.227 – ident: e_1_2_5_7_1 doi: 10.1002/mnfr.200500025 – ident: e_1_2_5_10_1 doi: 10.1155/2010/651063 – ident: e_1_2_5_14_1 doi: 10.1002/mnfr.201300135 – ident: e_1_2_5_11_1 doi: 10.1002/oby.20109 – ident: e_1_2_5_24_1 doi: 10.1210/en.2005-0473 – ident: e_1_2_5_20_1 doi: 10.1038/oby.2006.77 – ident: e_1_2_5_23_1 doi: 10.1210/en.2005-0237 – ident: e_1_2_5_22_1 doi: 10.1016/j.brainres.2005.02.065 – ident: e_1_2_5_21_1 doi: 10.1124/mol.109.058677 – reference: 24499148 - Crit Rev Food Sci Nutr. 2014;54(9):1158-66 – reference: 23818307 - Mol Nutr Food Res. 2013 Nov;57(11):2071-4 – reference: 17024038 - Curr Opin Gastroenterol. 2000 Mar;16(2):178-83 – reference: 17030963 - Obesity (Silver Spring). 2006 Sep;14(9):1523-34 – reference: 20798767 - J Nutr Metab. 2010;2010:null – reference: 15926145 - Mol Nutr Food Res. 2005 Jun;49(6):560-70 – reference: 23385525 - Curr Opin Gastroenterol. 2013 Mar;29(2):190-4 – reference: 22516953 - J Nutrigenet Nutrigenomics. 2012;5(1):26-44 – reference: 24114492 - Cancer Treat Res. 2014;159:377-99 – reference: 21638778 - Mol Nutr Food Res. 2011 Oct;55(10 ):1499-508 – reference: 16741270 - Obesity (Silver Spring). 2006 Apr;14(4):683-9 – reference: 19837904 - Mol Pharmacol. 2010 Jan;77(1):46-57 – reference: 19739641 - J Agric Food Chem. 2009 Oct 14;57(19):8844-51 – reference: 18948970 - Obesity (Silver Spring). 2009 Jan;17(1):40-5 – reference: 23337772 - Int J Obes (Lond). 2013 Oct;37(10):1391-8 – reference: 21831780 - Benef Microbes. 2010 Nov;1(4):423-31 – reference: 15862527 - Brain Res. 2005 May 10;1043(1-2):139-44 – reference: 9361845 - Adv Exp Med Biol. 1997;427:201-10 – reference: 18796545 - Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1160-6 – reference: 23784900 - Obesity (Silver Spring). 2013 May;21(5):981-4 – reference: 15932924 - Endocrinology. 2005 Sep;146(9):3748-56 – reference: 23630079 - Obesity (Silver Spring). 2014 Feb;22(2):344-8 – reference: 16150917 - Endocrinology. 2005 Dec;146(12):5120-7
SSID	ssj0031243
Score	2.3211124
Snippet	Resistant starch (RS) is a dietary fermentable fiber that decreases body fat accumulation, and stimulates the secretion of glucagon‐like peptide‐1 (GLP‐1) and... Resistant starch (RS) is a dietary fermentable fiber that decreases body fat accumulation, and stimulates the secretion of glucagon-like peptide-1 (GLP-1) and...
SourceID	pubmedcentral proquest pubmed crossref wiley istex
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	1000
SubjectTerms	Adipose Tissue - metabolism Animals Antagonist antagonists body fat body weight Dietary Fiber Dietary Fiber - pharmacology fermentation food intake gene expression genotype GLP-1 receptor glucagon-like peptide 1 Glucagon-Like Peptide 1 - blood Glucagon-Like Peptide 1 - physiology intraperitoneal injection messenger RNA Mice Obesity peptide YY Peptide YY - blood Peptide YY - physiology PYY receptor resistant starch secretion Starch - pharmacology
Title	The importance of GLP-1 and PYY in resistant starch's effect on body fat in mice
URI	https://api.istex.fr/ark:/67375/WNG-52H21RM4-S/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmnfr.201400904 https://www.ncbi.nlm.nih.gov/pubmed/25631638 https://www.proquest.com/docview/1680183063 https://www.proquest.com/docview/1803115132 https://pubmed.ncbi.nlm.nih.gov/PMC5553290
Volume	59
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZQuXDh_QgvGQm1p7SJX0mOiLJdIbqqFirak-X4oa7adVA3KwEnfgK_kV_SsbMJXZ5CXHxwJko8mfF8E48_I_RcCWFya2H2K-MyI3VpqZROBWUqMyq0ke1zIsaH7PURP7q0i7_jhxh-uAXPiPN1cHBVL3a-k4bOvQt8npAgZFUkBA0FWwEVTQf-KArBK1bYQ8yC9yC8Z23MyM767WtR6WpQ8MdfQc6fKycvI9oYkkY3kOoH01WinG4v23pbf_6B5_F_RnsTXV_hVfyiM7Bb6Ir1t1GyO7Mt3sQrUtEzPOk5_e-gKRgens0jrAeDwo3De28Ovn35mmPlDT44PsYzjyHJD8DVtxhacLWtBe4qS3Djcd2YT9ipNgjOYSK7iw5Hr969HKergxtSDemLSCvN61obCrljqaxxlmhinS3y3BWQbjlGrWA1d2Efe1UQYy0jDvq11pkRmaX30IZvvH0QKq-4UaSqHeMZILe81EwzIwrCjDJ5ViUo7T-c1CtW83C4xpns-JiJDJqTg-YStDXIf-j4PH4ruRntYBBT56ehCq7g8v1kT3IyJvl0n8m3CXrWG4oE3wwLLsrbZrmQuYD4X0JSRv8gU2aB8CinJEH3O-ManghwlAa8nKBizewGgcANvn7Fz04iRzjnnJIqA_VEq_rLWOX-ZDQllImH_yj_CF2DTt5VgD5GG-350j4BlNbWT6MnXgBETDUy
linkProvider	Wiley-Blackwell
linkToHtml	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZQe4AL70d4Ggm1p7SJX0mOCNgusBtVSyvoyXL8EKt2E9RmJeDET-A38ksYO5vA8hTi4kMyUeLJjOcbe_wZoUdKCJNaC6NfHpYZqYtzpXQsKFOJUb4NbJ-lGB-yF294X03o98J0_BDDhJv3jDBeewf3E9K731hDF7XzhJ6QISSFZwTd9Md6h6xqNjBIUQhfocYeohZ8CeE9b2NCdtefX4tLm17F738FOn-unfwe04agNLqEqr47XS3K8c6yrXb0xx-YHv-rv5fRxRVkxY87G7uCztn6Koqezm2Lt_CKV_QElz2t_zU0A9vD80VA9mBTuHF4b7L_5dPnFKva4P2jIzyvMeT5HrvWLYYWvG37DHfFJbipcdWYD9ip1gsuYCy7jg5Hzw6ejOPV2Q2xhgxGxIXmVaUNhfQxV9Y4SzSxzmZp6jLIuByjVrCKO7-VvciIsZYRB9e11okRiaU30Ebd1PaWL77iRpGicownAN7SXDPNjMgIM8qkSRGhuP9zUq-Izf35Gieyo2Qm0mtODpqL0PYg_66j9Pit5FYwhEFMnR77QriMy9flnuRkTNLZlMlXEXrYW4oE9_RrLqq2zfJMpgIgQA55Gf2DTJ54zqOUkgjd7KxreCMgUuohc4SyNbsbBDw9-Pqdev420IRzzikpElBPMKu_9FVOy9GMUCZu_6P8A3R-fDCdyMnz8uUddAEEeFcQehdttKdLew9AW1vdD275FXnMOU0
linkToPdf	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LbtQwFLVQKyE2vKHhaSTUrtImfiVZIobpAO1oNFDRrizHDzFqJ6najASs-AS-kS_h2pmEDk8hNl7EN0rsnGufG18fI_RUCWFSa2H0y8MyI3VxrpSOBWUqMcqXQe1zLEYH7NUhP7ywi7_Vh-h_uHnPCOO1d_BT43a-i4bOK-f1PCFASAovCLrORJJ7XA-mvYAUhdkrpNjDpAUvQngn25iQndX7V6aldd_DH37FOX9OnbxIacOcNLyGVNeaNhXleHvRlNv60w9Cj__T3Ovo6pKw4mctwm6gS7a6iaLBzDZ4Ey9VRU_wuBP1v4WmgDw8mwdeD4jCtcO7e5Ovn7-kWFUGT46O8KzCEOV75lo1GErwta1z3KaW4LrCZW0-YqcabziHkew2Ohi-ePt8FC9Pbog1xC8iLjQvS20oBI-5ssZZool1NktTl0G85Ri1gpXc-Y3sRUaMtYw4uK61ToxILL2D1qq6shs-9YobRYrSMZ4AdUtzzTQzIiPMKJMmRYTi7sNJvZQ196drnMhWkJlI33Oy77kIbfX2p62gx28tNwMOejN1duzT4DIu3413JScjkk73mXwToScdUCQ4p19xUZWtF-cyFUAAcojK6B9s8sQrHqWUROhuC67-icBHqSfMEcpWYNcbeHHw1Zpq9j6IhHPOKSkS6J6Aqr-0Ve6Ph1NCmbj3j_aP0eXJYCj3Xo5f30dXoJ632aAP0FpztrAPgbE15aPglN8Av8w4BQ
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+importance+of+GLP%E2%80%901+and+PYY+in+resistant+starch%27s+effect+on+body+fat+in+mice&rft.jtitle=Molecular+nutrition+%26+food+research&rft.au=Zhou%2C+June&rft.au=Martin%2C+Roy+J&rft.au=Raggio%2C+Anne+M&rft.au=Shen%2C+Li&rft.date=2015-05-01&rft.issn=1613-4125&rft.volume=59&rft.issue=5+p.1000-1003&rft.spage=1000&rft.epage=1003&rft_id=info:doi/10.1002%2Fmnfr.201400904&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1613-4125&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1613-4125&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1613-4125&client=summon